Laurus Labs Limited Financial Ratios
LAURUSLABS · Healthcare · Current price ₹2,060.1
P/E ratio
125.1x
P/B ratio
19.7x
ROE
16.8%
ROCE
17.6%
Debt / Equity
0.45
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 125.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 19.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.45 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Laurus Labs Limited's latest numbers.
Laurus Labs Limited profitability
Laurus Labs Limited generates a return on equity of 16.8% and a return on capital employed of 17.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.45 and a P/E of 125.1x, Laurus Labs Limited is conservatively financed. Our overall business-quality score for the company is 4.5 / 10.
Understand the ratios
More on Laurus Labs Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.